GSK influenza virus H5N1 vaccine 1557484A
112576
Phase 2 mab terminated
Quick answer
GSK influenza virus H5N1 vaccine 1557484A for Influenza is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Influenza
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated